https://www.selleckchem.com/pr....oducts/adenine-sulfa
These results warrant caution for the use of these medicines during the first trimester of pregnancy.The management of patients with triple-negative breast cancer (TNBC) continues to pose a significant clinical challenge. Less than 30% of women with metastatic TNBC survive 5 years, despite adjuvant chemotherapy and the initial higher rates of clinical response that can be achieved with neoadjuvant chemotherapy. ImmunoBody® is a plasmid DNA designed to encode a human antibody molecule with complementary determining regions (CDRs)
Like
Comment
Share
